Skip to main content
TipRanks
Go Ultimate75% OFF

Alphamab Oncology (9966) Income Statement

2 Followers

Alphamab Oncology Income Statement

Last quarter (Q2 2026), Alphamab Oncology's total revenue was ¥271.54M, an increase of 56.45% from the same quarter last year. In Q2, Alphamab Oncology's net income was ¥-40.51M. See Alphamab Oncology’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 551.58M¥ 640.08M¥ 218.77M¥ 166.84M¥ 146.02M
¥ 426.67M¥ 579.77M¥ 163.54M¥ 122.64M¥ 142.99M
¥ 575.99M¥ 479.26M¥ 487.09M¥ 555.18M¥ 558.91M
Depreciation and Amortization¥ 64.68M¥ 77.03M¥ 69.12M¥ 55.19M¥ 41.10M
¥ -84.64M¥ 178.04M¥ -129.30M¥ -377.18M¥ -358.13M
¥ -149.32M¥ 101.01M¥ -305.55M¥ -432.37M¥ -415.62M
¥ 38.33M¥ 65.84M¥ 112.96M¥ 106.82M¥ 3.50M
¥ -110.99M¥ 166.34M¥ -210.59M¥ -325.72M¥ -412.42M
¥ -110.99M¥ 166.34M¥ -210.59M¥ -325.72M¥ -412.42M
Per Share Metrics
Basic EPS¥ -0.12¥ 0.17¥ -0.22¥ -0.35¥ -0.44
Diluted EPS¥ -0.12¥ 0.17¥ -0.22¥ -0.35¥ -0.44
Weighted Average Shares Outstanding961.40M978.48M959.90M930.63M935.49M
Weighted Average Shares Outstanding (Diluted)961.40M984.19M959.90M936.50M935.49M

Currency in CNY

Alphamab Oncology Earnings and Revenue History

-1.6B-800M0800M-20000 %0 %20000 %40000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin